How do teams share funds?

Long before immunotherapy made headlines, Georgetown Lombardi’s Dr. Michael B. Atkins believed in its potential. Now, he rides with those it saved.

BellRinger has raised over $4.6 million for cancer research since 2022, and in our fourth year, our community’s impact is more critical than ever.

Meet a few members of Team Balfour Beatty-Gilbane and why they’re participating in BellRinger 2024!